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Abstract 
 
Introduction: The field of nanomedicine, utilising nano-sized vehicles (nanoparticles and nanofibres) 
for targeted local drug delivery, has a promising future. This is dependent on the ability to analyse the 
chemical and physical properties of these drug carriers at the nanoscale and hence atomic force 
microscopy (AFM), a high-resolution imaging and local force-measurement technique, is ideally suited. 
 
Areas covered: Following a brief introduction to the technique, the review describes how AFM has 
been used in selected publications from 2015-2018 to characterise nanoparticles and nanofibers as 
drug delivery vehicles. These sections are ordered into areas of increasing AFM complexity: 
imaging/particle sizing, surface roughness/quantitative analysis of images and analysis of force curves 
(to extract nanoindentation and adhesion data). 
 
Expert opinion: AFM imaging/sizing is used extensively for the characterisation of nanoparticle and 
nanofibre drug delivery vehicles, with surface roughness and nanomechanical/adhesion data 
acquisition being less common. The field is progressing into combining AFM with other techniques, 
notably SEM, ToF-SIMS, Raman, Confocal and UV. Current limitations include a 50 nm resolution limit 
of nanoparticles imaged within live cells and AFM tip-induced activation of cytoskeleton proteins. 
Following drug release real-time with AFM-spectroscopic techniques and studying drug interactions 
on cell receptors appear to be on the horizon. 
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Article Highlights 
 
 Atomic force microscopy (AFM), a high-resolution imaging and local force measurement 
technique, is becoming increasing established as a tool for characterising drug delivery 
vehicles. 
 The majority of AFM studies of nanoparticles and nanofibres are focused on imaging and 
particle sizing, the latter of which is in close-agreement with measurements obtained from 
dynamic light scattering and electron microscopy.  
 Surface roughness and data have been obtained from AFM images of nano-sized drug 
delivery systems; the acquisition of nanomechanical properties (nanoindentation and 
adhesion) from AFM force curves of such systems have also been reported, although to a 
lesser extent. 
 The field is progressing into combining AFM with other techniques (such as SEM, ToF-SIMS, 
Raman, Confocal and UV). Many of these promise the potential to follow drug release real-
time and for studying drug interactions on cell receptors. 
This box summarises key points contained in the article. 
 
1. Introduction 
 
Progress in drug design has led to the development of new peptides, proteins and drug molecules that 
can be used to treat a variety of diseases. However, the limited ability to selectively deliver these 
molecules, at well-defined dosing regimens and without invoking drug-resistance, remains a 
significant challenge. Nanomedicine is the application of nanotechnology to human healthcare for 
diagnosis, monitoring, treatment, prediction and prevention of diseases [1]. Nanomedicines consist of 
nanoparticles or nanofibres (typically with one dimension < dia. 100 nm) that usually contain drugs 
that can be delivered to target tissues or organs [2-4]. Improved therapeutic outcomes have been 
demonstrated through the use of such delivery systems [5]. Methods to evaluate the effectiveness of 
nanomedicines, and indeed the nanotoxicological effects of nanoparticles in general [3,6,7], continue 
to be developed. Atomic force microscopy (AFM), used in the fields of materials characterisation and 
life sciences [8-14], is becoming increasing established as a tool for characterising drug delivery 
vehicles and is the focus of this review. 
 
AFM is the principal member of number of related scanning probe techniques that can provide high-
resolution imaging and/or local surface property measurements of samples/specimens [15]. The 
technique was developed in 1986 by Binnig et al. [16], building upon the successes of their previously 
invented scanning tunnelling microscope (STM), where atomic-scale imaging of metallic and 
semiconducting materials was established. This was achieved by scanning a small, conducting tip 
across a surface and measuring the tunnelling current between the two upon the application of a bias 
potential [17]. The desire to scan insulating materials, such as polymers and biological specimens, was 
the driving force for the development of the AFM [15]. Here, the force between a tip and sample is 
monitored rather than the acquisition of a tunnelling current. Strictly speaking, in the field of biology, 
STM could allow imaging of small biomolecules, proteins and DNA due to small tunnelling distances, 
albeit the conduction mechanism remains poorly understood [18-20]. 
 
Following a brief overview of the technique, this review aims to provide a selection of the numerous 
examples of how AFM is currently being used to investigate and characterise drug delivery vehicles. 
Publications have been chosen from the period 2015 to 2018. Our opinions on the applications and 
future direction in this field are included in the final section of this review. 
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1.1 Fundamentals 
 
In AFM, a small, sharp tip, prefabricated on a cantilever (together often referred to as a probe), is 
either scanned across (x,y-plane) or moved perpendicular to (z-plane) a surface of interest. Depending 
on the type of AFM, either the probe or the sample is fixed to a piezoelectric ceramic scanner. The 
piezoelectric crystals in the scanner change length on the application of a potential difference applied 
across them, with a near-linear relationship between these properties and accurate to 0.1 Å; this 
feature gives AFM its high-resolution capability, and ability to overcome the Rayleigh criterion 
(resolution limited to wavelength of light in optical microscopy, or wavelength of electrons in electron 
microscopy) [15]. 
 
A laser is reflected off the back (opposite tip side) of the cantilever and onto a photodetector via a 
mirror (Fig. 1). This provides a method of tracking the position of the tip. As the cantilever is deflected 
(in x, y and z planes), the laser signal falls on a different region of the photodetector; this signal is 
converted to a voltage. This can be used, for example, to move the scanner (sample or tip), relieving 
the deflection on the cantilever, for example, depending on the acquisition mode. This is often 
referred to as the feedback (loop) circuit, with scanners being referred to as open- or closed-loop 
depending on their linearity of movement. 
 
 
Figure 1. Schematic of the main components of a typical AFM, with particles on a mica surface. 
 
AFM requires minimal sample preparation and can be used in a number of operating modes, although 
is not confined to topographical imaging. The simplest mode is known as contact mode, where the tip 
Expert Opinion on Drug Delivery. Postprint version. Accepted 07/11/2018. 
Doi:10.1080/17425247.2018.1546693 
 
4 
 
just touches the sample and there is a small deflection on the cantilever as the probe scans across the 
surface building up the image [15]. The applied voltage through the z-piezo to maintain the sample 
cantilever deflection is used as the z-component (z-scale) in the resultant topography image. A 
problem with this mode is that lateral forces can move loosely adsorbed or delicate/soft structures on 
the surface, such as DNA, and so Tapping Mode® or non-contact AFM modes are preferred. In Tapping 
Mode®, as the name suggests, the probe is vibrated vertically at its resonant frequency whilst scanning 
the surface. The cantilever deflection is monitored when the tip touches the surface, but the probe is 
moved when the tip and sample are not in contact, thus significantly reducing the later forces. Non-
contact mode is similar, although no tip-sample contact is made. Instrument manufacturers tend to 
have their own trade mark names for some modes, such as Torsional Resonance (TR) Mode® [21], 
PeakForce Tapping® (PFT) and PeakForce Quantitative Nanomechanical Mapping (QNM®) [22]. In 
addition to topography imaging, frictional [23-25], magnetic (magnetic force microscopy, MFM), 
adhesion and compression forces can be measured and mapped; the latter two achieved by pulling 
the probe away from or pushing it into the surface. These approaches have been developed, for 
example, by attaching a ligand to the probe and mapping receptor-binding sites on cell surfaces, with 
a lateral resolution of a few nanometres, whilst simultaneously acquiring the topography image; this 
is known as topography and recognition imaging (TREC) mode [26] or single-molecule force 
spectroscopy (SMFS) [27]. Quantitative information is obtained from the acquired force vs. distance 
plot (force curve) [28-30]. 
 
There are numerous types of probes (cantilevers with integrated tips) available and selection will 
depend on the scanning mode and application. The most appropriate tip for the sample must be 
selected: sharp tips give good resolution on rigid samples but can penetrate soft regions of a sample. 
The tip can be sharp with a radius < 2 nm or blunt, such as having an attached 500 µm dia. microbead; 
the latter are usually mounted on “tipless cantilevers”. Other factors that must be decided include: 
the tip material (important if the tip will be chemically functionalised), the length of the cantilever, 
the flexibility (spring constant) of the cantilever and the force applied to the sample by the tip. 
 
Contact mode probes tend to be made from silicon nitride due to the material being hard wearing. 
Tapping mode and non-contact mode tips are usually comprised of silicon since it is stiff and provides 
cantilever spring constants in the relevant range. The tip profile can have various profiles (aspect 
ratios) depending on the nature of the surface to be explored; for example, if the surface has features 
sharper than the tip profile, artefacts can result and so a sharpened (high aspect ratio, etched) tip 
would be required [31]. 
 
Cantilevers may even be tip-less, if a material is be attached and used as a tip; this maybe to investigate 
the required tip-sample force interactions with relevant chemistry/biology [32], or to provide a sharp 
tip (e.g., by the attachment of carbon nanotubes) [33]. The top and/or bottom surface of the probe 
may be coated. Top coatings (laser side) are to make the cantilever more reflecting, and are often 
made of aluminium or gold. Bottom surfaces may be coated with gold, via a titanium adhesion layer, 
to enable self-assembled monolayers to be grafted or other surface modification useful in chemical 
force microscopy (CFM) [34-36]. Cantilevers can also be functionalised with proteins/fibronectins to 
investigate the behaviour on polymers in aqueous solutions, which will provide information on the 
potential of new materials to be used in human body (e.g., molecular interactions) [37]. 
 
Other related probe techniques include electrochemical AFM (EC-AFM) [38], electrostatic force 
microscopy (EFM) [39], kelvin probe force microscopy (KPFM) [40], photoconductive AFM (pcAFM) 
[41], scanning capacitance microscopy (SCM) [42], surface potential microscopy (SPoM) [43], scanning 
spreading resistance microscopy (SSRM) [44] and scanning thermal microscopy (SThM) [45]. 
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2. Application of AFM in drug delivery vehicle characterisation 
 
There are a vast array of nanosized carriers for drug delivery, including liposomes/micelles, polymers 
systems, porous silica, magnetic materials, graphene and mesoporous carbon nanospheres, that can 
take the form of particles, rods, tubes or sheets. Nanocarriers can help deliver drugs with poor 
aqueous solubility, low permeability, and extensive first pass metabolism. There are a number of 
release-type mechanisms, such as rapid, delayed, slow, pulsatile, local, and targeted drug release. 
Ideally, targeted drug delivery can improve the therapeutic response and maximise drug 
concentration to the target site. The drug release can be into a tissue or even within cells. Intracellular 
release is an important goal for anti-cancer drugs which often target processes in the nucleus (e.g., 
cyclophosphamide’s active metabolite causes deleterious DNA crosslinking).   
 
In this section, we summarise a variety of publications that have used AFM to characterise 
nanoparticles and nanofibres. The subsection on nanoparticles has been subdivided into groups of 
increasing AFM complexity: imaging, surface roughness (quantitative analysis from the images), and 
analysis of data/images from force vs. distance curves (nano-hardness, adhesion etc). 
 
2.1 Nanoparticles 
 
Nanoparticles used in drug delivery applications (typically < 200–500 nm) usually comprise of 
nanospheres, nanocapsules and nanosized emulsions [46]. Nanoparticles harness the opportunities 
to make drug delivery more precise and to improve other characteristics such as their therapeutic 
index. They show promise as drug carriers due to their variable size, shape, porosity and surface 
properties [47,48] and these parameters also have an important role to play in the in vivo 
biodistribution. For characterising such particles, AFM has been used for confirming shape (different 
shaped nanoparticles can affect transport pathways, degradation and targeting), size, surface 
roughness, surface charge (known to affect cellular uptake) and to a lesser degree 
nanomechanical/adhesion properties. These aspects are considered below. 
 
2.1.1 Imaging and particle sizing 
 
Eaton et al. directly compared nanoparticle size measurements obtained using AFM, SEM, TEM and 
dynamic light scattering [49]. The optimal suitability of each technique was dependent on sample type 
and size; for example, the metal coating of nanoparticles required for SEM had a 14 nm thickness and 
thus introduced a significant error when examining small nanoparticles. The authors did note that 
higher throughput measurements of particle size were achievable from TEM compared with AFM. 
Placzek & Kosela reviewed and compared the use of a range of microscopy methods for the analysis 
of submission phospholipid dispersions, particularly with reference to drug delivery systems [46]. 
Particle sizing and physical properties measurements were emphasised when discussing AFM 
examples. Bazylińska used AFM imaging (TappingMode®, TEM and DLS to characterise PEG-ylated 
nanocarriers, produced from a double emulsion process, that encapsulated both DNA (hydrophilic and 
a biomolecule example) and a hydrophobic thiazole orange dye [50]; different polymer stabilising 
agents were investigated (Fig. 2). Particle size data from each technique were comparable. TEM 
showed the core shell morphology, with the darkest region corresponding to a denser polymeric/PEG-
ylated corona (Fig. 2a), and AFM showed an absence of enhanced aggregation (for all nanocarriers) 
investigated. Ramezanpour et al. reviewed computational and experimental approaches for 
investigating nanoparticle-based drug delivery systems [51]. Nanoscale vertical resolution of 0.01 nm 
is noted for AFM measurements, with particle size, dispersity, shape and surface morphology 
complementing the same properties obtained by SEM and TEM. Watanabe et al. used AFM to measure 
particle diameters of AmBisome, an antimycotic nanomedicine containing amphotericin B, as a 
function of methanol dilution and pH and to compare with values obtained from dynamic light 
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scattering results [3]. AFM allowed such measurements to be performed that were not dependent on 
viscosity and so were in more accurate than DLS measurements, particularly at ca. 100 nm. Zhang et 
al. produced intestinal mucous-penetrating core-shell nanocomplexes by functionally mimicking the 
surface of a virus [52]; TappingMode® AFM showed the nanocomplexes were spherical or sub 
spherical, with the coating process increasing the particle size from 100 to 300 nm, in agreement with 
DLS results. Single and double emulsion poly(lactic-co-glycolic acid) (PLGA) nanoparticles 
encapsulating an AKT/PDK1 inhibitor (PHT-427) for targeting pancreatic tumours have been imaged 
using Tapping mode® AFM, which confirmed the expected spherical geometry [53]. TappingMode® 
AFM has also been used to image nanoparticles formed from poly(lactic acid) and alkylglyceryl-
modified dextran designed to carry drugs across the blood-brain-barrier [54]. 
 
 
Figure 2. Example TEM and AFM images (2D and 3D-rendition) and DLS size distribution graphs (left-to-right) of 
DNA and hydrophobic thiazole orange-co-loaded nanocarriers stabilised by Cremophor A25 with (a) 
poly(ethylene glycol) methyl ether-block-poly(D,L-lactide) (PEG-PDLLA), (b) PEG-PCL, and (c) PEG-PLGA 
polymeric shell; DH = mean diameter (nm); PdI = polydispersity index [50]. Reproduced with permission. 
 
The size of protein nanocarriers was investigated by Ping et al. and the results compared with TEM 
and DLS studies [55]. The mean particle sizes were similar with all three techniques, however AFM 
was reported ‘easier’ with less processing involved and proteins around the particle formulations were 
more readily observable. 
 
Masarudin et al. used AFM to analyse the morphology, size and surface topology of chitosan 
nanoparticles (CNPs) with diameters as small as 45 nm [56]. The sizes measured using AFM were 
slightly smaller than those from DLS studies, however this is due to dehydration of the samples, as is 
well reported in the literature. Using different formulation methods, aggregations of nanoparticles 
were observed using AFM that were not visible employing other techniques. AFM revealed 
nanoparticles of chitosan containing 2-oxothiazolidine-4-carboxylic acid for ocular delivery to be 
spherical, of uniform shape and with limited aggregation, supporting SEM investigations [57]. 
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Akanda et al. used AFM to reveal the particles sizes of empty and loaded (retinoic acid, an anticancer 
agent) solid lipid nanoparticles (SLNs; 117.8 ± 11.0 and 169.8 ± 21.0 nm, respectively) [58]; however, 
these sizes were smaller than those measured using laser diffraction measurements and this was 
attributed to sample drying and a slight flattening effect caused by the AFM probe. Interestingly, Cai 
et al. found the mean diameters of polystyrene nanoparticles (for skin penetration) to be significantly 
less than those obtained from photon correlation spectroscopy (PCS) (36.8 ± 7.3, 56.9 ± 0.7 nm, 
respectively), although the AFM values were considered to be more accurate due to direct interaction 
of the materials [59]; SiO2 nanoparticles, however, exhibited no difference in particle diameter when 
examined by AFM and PCS and this was attributed to variations in surface charge. 
 
AFM and other techniques were used by Engelhardt et al. to characterise liposomes, made from 
tetraether lipids from the archaea Sulfolobus acidocaldarius, cholesterol and 1,2-dioleoyl-3-
trimethylammonium-propane [60]. The liposomes, for use as gene delivery vectors, were 
subsequently combined with a luciferase expressing plasmid (pCMV-luc) to produce lipoplexes. AFM 
images of lipoplexes revealed “onion-like” structures, where pDNA was wrapped around liposome 
cores with further alternating layers. AFM was used in conjunction with DLS measurement to confirm 
that cholesterol is required for producing well-organised and stable liposomes containing atenolol and 
quinine [61]. 
 
AFM has been used to investigate the efficacy of ultrasound mediated drug delivery [62]. Here, 
topography images of a cell surface treated with doxorubicin-loaded temperature-sensitive liposomes 
were acquired as a function of temperature. At 42 °C after 4 h, squamous structures were observed 
that increased in severity with prolonged treatment. 
 
Extracellular vesicles (EVs) are small (< 1 μm) phospholipid vesicles that enable the transport of 
proteins and genetic material between cells [63]. Nanoscale exosomes (EXOs) are a subcategory of 
EVs that originate from the endosomal system and have very small sizes (30 - 150 nm) [64]. EXOs are 
released from cancer cells and tumour microenvironment (TME) stromal cells to promote tumour-
induced immune suppression, angiogenesis and metastasis [65] and they also exhibit distinct markers 
for cancerous tumours, of use as early diagnostic tool [66-68]. EXOs also show promise in drug delivery 
of immunotherapeutic agents [69]. Parisse et al. commented on a survey by Gardiner et al. [70] that 
< 10% of studies characterising EVs reported the use of AFM techniques [64]. This was partly attributed 
to the difficulties in immobilising such particles for AFM characterisation, of which the authors then 
go on to overview such strategies; imaging in liquid was deemed to be most important. 
 
Ping et al. observed particle sizes of suckerin-19 (S-19)/DNA complexes generally decreased with 
increasing protein/ DNA nitrogen-to-phosphorus (N/P) ratios [55]. Uncomplexed DNA were seen at a 
low N/P ratio (equal to one). Nanoparticles of 100-200 nm were able to encapsulate hydrophilic drugs 
to inhibit tumour growth. Imaging of DNA nanoparticles encapsulating buparlisib (BKM120; a PI3K 
inhibitor) in high efficiency for treatment of chronic lymphocytic leukaemia confirmed the spherical, 
near-monodispersed population of this material [71]. 
 
Arora et al. used AFM to image and size of cytotoxic 5-methylmellein (5-MM)-loaded bovine serum 
albumin nanoparticles in their investigations; 5-MM is a secondary metabolite from Xylaria psidii [72]. 
AFM imaging black phosphorus nanoparticles revealed the structures to have a platelet-like form, with 
sizes of 100-500 nm (in agreement with dynamic light scattering measurements) and much smaller 
thicknesses [73]; these nanoparticles were functionalised with cisplatin and oxaliplatin and used 
against ovarian cancer cells. 
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Paul et al. used TappingMode® AFM (topography and phase imaging) and combined AFM-confocal 
microscopy to image molecularly imprinted polymers based on insulin [74]; images with and without 
the protein were recorded. TappingMode® was also used by Fatouros et al. to produce size histograms 
of peptide nanovesicles and to observe their necklace-like formations on mica after quick drying in air 
[75]; ImageJ was used to enhance surface features.  
 
The particle-size distribution of filtered vs. unfiltered commercially-available tattoo ink (30-600 and 
40-970 nm, respectively) obtained from AFM scanning on glass was reported by Grant et al. [76]. Cryo-
sections of skin tissue containing tattoo ink nanoparticles were also imaged using AFM and were 
comparable to those on glass. Dense collagen fibril networks and scar tissue from the tattooing 
process were also reported. 
 
2.1.2 Surface roughness 
 
Accurate characterisation of nanoscale surface roughness is important in many applications, including 
drug delivery applications. Surface roughness can be measured by using a number of techniques, 
however the most accurate technique for nanoparticles is AFM; here, height deviations from a mean 
height obtained from line-transects drawn across AFM images (datasets) are used; there are 
numerous roughness parameters available (e.g., Ra, Rq, Rz, Rmax), although the arithmetic roughness 
average, Ra, is the most widely used [77]. 
 
Surface roughness values were obtained from AFM images of spray-dried and spray-freeze-dried silk-
based nanoparticles; the latter had much larger values (Ra 421 c.f. 27 nm) and were therefore judged 
more favourable for improved dispersion and enhanced aerosolisation efficiency for their use as lung 
cancer delivery agents (encapsulating cisplatin) [78]. 
 
Perli et al. obtained AFM images and roughness values of silver nanoparticles coated with chitosan 
(stabilising agent and anticoagulant) for antimicrobial applications [79]. Surface roughness (RMS) was 
found to decrease with increasing chitosan concentration, probably due to the formation of a uniform 
coating. AFM also revealed a particle diameter of ca. 160 nm. The paper then explored imaging of the 
uncoated silver nanoparticles (dia. 30 nm) loaded into poly(ε-caprolactone) scaffolds produced by 
electrospinning (Fig. 3). TappingMode® AFM imaging was used to support SEM and TEM imaging of 
silver nanoparticles for targeting A549 lung cancer cells [80]; surface topography, roughness, bearing 
ratio and amplitude variation data were presented. The surfaces of silk nanoparticles for use as drug 
delivery vehicles were imaged using AFM by Kumar & Singh [81]; surface roughness was also assessed. 
 
2.1.3 Nanomechanical/adhesion properties 
 
Marchetti et al. reviewed the use of AFM nanoindentation measurements in virology [82]. Valuable 
information concerning the mechanics of capsid-genome interactions, morphological changes driving 
viral maturation, capsid stabilising factors and viral uncoating may all be gained, highlighting the link 
between mechanics and infectivity, and having nanomedicinal implications. 
 
Reggente et al. used contact resonance AFM (CR-AFM) subsurface nanomechanical imaging to locate 
stiff (magnetic) nanoparticles embedded in soft biological tissue [83], opening the way for further 
advancements in drug delivery and nanotoxicology. In this contact mode technique, an ultrasonic 
transducer is mounted on the back of the sample and out-of-plane oscillations are excited; resonance 
frequencies of the cantilever-tip–sample system (contact resonance frequencies, CRFs), 
corresponding to local elastic properties, area then recorded and mapped alongside topography 
images. 
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Figure 3. AFM topography images of poly(ε-caprolactone) scaffolds, (a,b) unloaded and (c,d) loaded with silver 
nanoparticles [79]. Reproduced with permission. 
 
Karagkiozaki et al. reviewed the use of nanomedicine in the treatment of thrombosis [84]. Whilst AFM 
has been used to image platelets on carbon nanocoatings [85], and show morphological alterations of 
platelets on nanomaterials [86], functionalisation of AFM tips with proteins for thrombosis elucidation 
has not yet been realised. Individual receptors have been identified, however, using force-mapping 
with AFM tips functionalised with antibodies [87]. 
 
While photon and electron microscopies can offer the opportunity to image a sample in 3D, AFM is 
unique in being able to determine material’s nanomechanical properties as well as imaging its surface 
and track an object over time. Mapping the nanomechanical properties (principally stiffness and 
adhesion) is referred in AFM as quantitative nanomechanical mapping (QNM). QNM is ideal for 
biological samples, and some of its many potential uses include tracking particles, diagnosing cancer, 
understanding cellular responses to changing conditions, and investigating adhesion. PeakForce QNM 
mode AFM was used by Gebril et al. to characterise their developed lipid formulations for evaluating 
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mechanical properties (e.g., Young’s Modulus), as well as size (Fig. 4) and surface roughness, of their 
nanoformulations [88]. The mechanical data clearly showed that gonadotrophin-releasing hormone 
conjugates had a significant effect on the lipid membrane, but not on the shape, and they were also 
able to see differences on the mechanical properties when a variety of lipid concentrations had been 
used.  This was not possible with any other technique, especially for formulations that are in the 
nanometre-scale and with similar morphologies (e.g., spherical shape and size). 
 
 
 
Figure 4. Representative AFM images of (a) empty bilosomes, (b) loaded bilosomes, (c) empty non-ionic 
surfactant vesicles (NISV), (d) loaded NSIV, and (e) loaded NSIV with xanthan gum; scale bar = 100 nm [88]. 
Reproduced with permission. 
 
Cai et al. used AFM force measurements to demonstrate that tetracaine (a model drug) was strongly 
adsorbed onto a negatively-charged carboxyl-modified polystyrene nanoparticle through its methyl 
and amine functionalities (6 and 16-fold increases, respectively, compared to a CH3-CH3 interaction) 
[89]; adhesion values to silica nanoparticles were much reduced, owing to their much lower surface 
potentials. 
 
A research paper entirely focused in the detection and measurement of the viscoelastic nano-
mechanical properties (called contact-resonance, CR) of magnetic nanoparticles in soft biological 
matrices by AFM was reported by Reggente et al. (2017) [83]; CR-AFM can be used as a promising 
technique for subsurface imaging of nanomaterials in biological samples. 
 
2.3 Nanofibres 
 
Nanofibre mats produced from electrospinning are very attractive as delivery vehicles since they are 
biodegradable and biocompatible [90-92]. They are also very attractive due to their huge surface area-
to-volume ratio [93]. The mechanical properties and the compatibility is a key goal, which is 
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dependent on the material, density, compliance and electric charge of the mesh. Topography images 
and roughness measurements have been obtained on electrospun nanofibres for local and sustained 
release of rosuvastatin and heparin for use as endovascular stents [94]. The drugs with cellulose 
acetate were dissolved in N,N-dimethylacetamide and acetone and electrospun onto commercial Co-
Cr, Ni-Ti and stainless steel stents. The surfaces and roughness values of the coatings on all these 
substrates were comparable. In a study of magnetic nanoparticles (Fe3O4) embedded in 
poly(acrylonitrile)/poly(DL-lactide) electrospun fibres, AFM revealed the nanoparticles had become 
completely coated by the polymer to the extent that their positions along the fibres could not be 
ascertained [95]. Viana et al. used AFM to show the thickness, diameter and morphological differences 
between electrospun fibres and those also containing an antimicrobial polypeptide [96]. The authors 
also made note of diameter increases with respect to SEM measurements, being due to tip-sample 
convolution effects and/or dehydration with SEM samples (widely known phenomena). 
 
The dynamic phase separation within electrospun fibres of poly(vinylpyrrolidone) (PVP) / 
hydroxypropyl methylcellulose acetate succinate hydrophilic / hydrophobic polymer blends (drug 
carriers) have been investigated [97]. AFM revealed nanoscale phase separation was observed for 
electrospun fibres whereas micron-scale separation was apparent using conventional blending 
methods (film casting and spin-coating), which have implications for drug delivery. 
 
Barrientos et al. incorporated irgasan, and separately, levofloxacin (both antibacterial agents) into 
scaffolds [98]. AFM images showed crystals of levofloxacin on fibre surfaces, but not those of irgasan; 
in a related paper [99], the same drugs were incorporated with type I collagen and fibril banding on 
the levofloxacin-containing fibres was observed confirming the deposition of collagen (Fig. 5). 
 
Kaur et al. produced electrospun PAN-carbon nanotube (CNT) composite nanofibres [93]. AFM 
scanning revealed the surfaces to have increasing roughness with increasing levels of multiwalled-
CNTs. Poly(L-lactide) and poly(ε-caprolactone) (PCL) fibres loaded with 25-hydroxyvitamin D3 (an 
antibiotic precursor) have been electrospun and characterised by AFM and other techniques [100]. 
PCL fibres were smooth, but were rougher for poly(L-lactide), and more so after than encapsulation 
of the drug. 
 
Mucoadhesive fibres for drug delivery were produced by electrospinning poly(ethylene oxide) and 
mucoadhesive polymers carboxymethylcellulose, sodium alginate and poly(acrylic acid) [101]. AFM 
surface roughness measurements of fibres in simulated vaginal fluid showed the polymer blend 
containing carboxymethylcellulose to have the best prospects.  
 
Wali et al. prepared electrospun blends of ethyl hydroxyl ethyl cellulose (EHEC), hydrophobically 
modified EHEC (HM-EHEC) and poly(vinyl alcohol) from THF/water on to silicon wafers and the 
resultant nanofibre mats were analysed using AFM (to obtain film thickness and surface roughness) 
and other techniques [102]. Chlorhexidine digluconate was also incorporated into the mats. Film 
thickness was independent on rotation speeds, although surface roughness decreased with increasing 
rotation speed. These AFM measurements therefore established an optimal rotation speed (4500 
rpm) to achieve uniform roughness of coating in further experiments. In addition, PVA provided 
smoothness to the otherwise granular geometry of the HM-EHEC surface. 
 
Dzamukova et al. used AFM imaging to examine surface-absorbed nanotubes (halloysite nanotubes 
with physically-adsorbed dextrin, DX-HNTs) on human lung carcinoma epithelial cells (A549) and 
hepatocellular carcinoma cells (Hep3b) [103]; imaging of dried cells advantageously enabled probing 
of solid nanotubes agglomerates through the collapsed cell membranes. DX-HNTs were internalised 
differently in the two cell types, which could be exploited for different therapeutic treatments. 
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Figure 5. AFM images of electrospun nanofibres: (a) poly(lactic acid) (PLA) unloaded, (b) PLA-irgasan (IRG), (c) 
PLA-levofloxacin (LEVO), (d) PLA-collagen, (e) PLA-collagen-IRG, and (f) PLA-collagen-LEVO [99]. Reproduced with 
permission. 
 
Mendes et al. performed AFM nanoindentation measurements to obtain the Young’s Modulii of 
electrospun asolectin phospholipid fibres [104]. Values were 17.26 ± 1 MPa, being stiffer than similar 
materials (natural cholesterol and phosphatidylcholine, respectively 0.27 and 0.03 MPa) but having a 
lower stiffness than synthetic polymers, such as PLLA, PVA and PAN (0.5 to 0.9 GPa, 4 to 13 GPa, and 
5.72 to 26.55 GPa, respectively). 
 
3. Conclusions 
 
AFM continues to be used extensively for the characterisation of drug delivery vehicles, most of which 
fit broadly into the groupings of nanoparticles and nanofibres. The majority of studies present images 
of these drug carriers with reports of dimensions and their comparison with other techniques, such as 
DLS and TEM/SEM. A smaller subset of publications draw out surface roughness information from 
AFM images to make comparisons. The smallest subset of recent papers that report the 
characterisation of drug delivery vehicles using AFM (among other techniques) touch on the ability of 
the technique to acquire force vs. distance data, i.e., nanomechanical properties. This is unusual in 
that AFM is now an established, albeit still rapidly growing, technique and other fields more routinely 
use the nanomechanical acquisition aspects of AFM. This may reflect the difficulty, however, in 
obtaining such measurements from nanoparticle surfaces, especially in liquids where anchoring to 
suitable substrates can problematic. 
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4. Expert Opinion 
 
AFM is characterised by superior resolution and possible interaction mapping in the pN range. The 
technique has become essential in a variety of fields, including the characterisation of systems for 
drug delivery applications. Today, extensive imaging and spectroscopic techniques have been 
combined with AFM to provide more powerful analyses. These include SEM-AFM, 3D tomographic 
AFM, AFM-ToF-SIMS, AFM-Raman, AFM-Confocal Raman Microscopy, AFM-NanoIR and AFM-UV 
systems, among others. This is certainly an exciting time in both the development and application of 
AFM combined with optical imaging or/and spectroscopic techniques. 
 
In the future, it will be possible to use AFM to more closely follow chemical reactions that could be 
used to investigate how drugs interact with cells or bacteria. AFM will provide the high-resolution 
necessary to follow these nanoscale reactions that is not currently possible. The development of 
advanced microelectromechanical systems (MEMS) devices will enable AFM technology to be scaled 
down to fit onto a chip measuring ca. 1 cm2. This would allow such devices to be placed inside the 
human body to enable a better understanding of chemical and particle interactions and in real-time, 
with particular benefits in the field of nanotoxicology. 
 
Developments in the ability of AFM to measure electric and magnetic fields at increasingly higher 
resolution are also likely to be beneficial for the characterisation of nano-sized carriers, particular 
those that have electrical and magnetic stimuli as release mechanisms. 
 
Currently, the resolution of AFM images of nanoparticles inside live cells is limited to 50 nm. 
Mechanical measurements on living cells have an effect on microtubules or actin of the cytoskeleton, 
which can result in an increase in cellular stiffness. With the latest developments in AFM technology 
and chemistry, the study of the effect nanoparticles have on live cells is now possible and at 
increasingly higher resolution. Also, with the use of AFM-spectroscopic analysis, it will soon be possible 
to “follow” drug release inside tissues and further understand how drugs “attack” cancer cells, for 
example. This will be aided through the recently developed fast scanning AFM techniques, where real-
time acquisition, at least for flat samples, is possible through the use of small cantilevers. Further 
developments in high-speed scanning will continue, combined with high-resolution imaging showing 
how drug molecules interact with cells. 
 
There is an increase in the number of studies using AFM as the crucial technique, however, there is 
still a gap in the literature on the use of AFM to investigate adhesion mapping of cell receptors before 
and after the additions of drugs, and with the combination with spectroscopic techniques. This would 
be expected to be another future development of AFM in the field. 
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